{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:16:49Z","timestamp":1794658609157,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    SARS-CoV-2 continues to cause substantial morbidity and mortality, particularly in winter. During the SARS-CoV-2 pandemic, community prevalence surveys provided detailed monitoring of infection levels. The Winter Coronavirus (COVID-19) Infection Survey (WCIS), conducted in England and Scotland from the 14\n                    <jats:sup>th<\/jats:sup>\n                    November 2023 to the 7\n                    <jats:sup>th<\/jats:sup>\n                    March 2024, enabled the UK Health Security Agency to publish fortnightly estimates of community infection levels in England and Scotland. Unlike previous community prevalence surveys, WCIS conducted testing using Lateral Flow Device (LFD) tests, and featured a repeat testing design that enabled estimation of key epidemiological parameters. LFD tests have a substantially lower cost per unit than Polymerase Chain Reaction (PCR) tests which were used in previous SARS-CoV-2 prevalence surveys; however, they have a high false negative rate that must be accounted for to produce reliable estimates. In this manuscript, statistical methods to robustly estimate incidence and prevalence while adjusting for time-varying false negative rates are developed. This enabled timely and robust inference of the incidence and prevalence of SARS-CoV-2, stratified by age group, location and sex. Overall, the study design of WCIS overcame key limitations of earlier large-scale community prevalence studies and demonstrated the utility of LFD tests in infectious disease surveillance.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-67272-9","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:03:00Z","timestamp":1768593780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estimating COVID-19 incidence and prevalence using lateral flow tests in England and Scotland, 2023-2024"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-9201","authenticated-orcid":false,"given":"Martyn","family":"Fyles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8743-0817","authenticated-orcid":false,"given":"Jonathon","family":"Mellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Overton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1637-4803","authenticated-orcid":false,"given":"Alexander M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-747X","authenticated-orcid":false,"given":"Thomas","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"67272_CR1","unstructured":"UK Health Security Agency. COVID-19. https:\/\/ukhsa-dashboard.data.gov.uk\/topics\/covid-19 (2024)."},{"key":"67272_CR2","unstructured":"UK Health Security Agency, Surveillance of Influenza and other seasonal respiratory viruses in the UK, winter 2023 to 2024. https:\/\/www.gov.uk\/government\/statistics\/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-the-uk-winter-2023-to-2024\/surveillance-of-influenza-and-other-seasonal-respiratory-viruses-in-the-uk-winter-2023-to-2024#vaccination (2024)."},{"key":"67272_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas, D. et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat. Commun. 15, 2254 (2024).","journal-title":"Nat. Commun."},{"key":"67272_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2105\/AJPH.2023.307230","volume":"113","author":"P Elliot","year":"2023","unstructured":"Elliot, P. et al. Design and implementation of a national SARS-CoV-2 monitoring program in England: REACT-1 Study. Am. J. Public Health 113, 545\u20135544 (2023).","journal-title":"Am. J. Public Health"},{"key":"67272_CR5","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2105\/AJPH.2023.307381","volume":"113","author":"H Ward","year":"2023","unstructured":"Ward, H. et al. Design and implementation of a national program to monitor the prevalence of SARS-CoV-2 IgG antibodies in england using self-testing: the REACT-2 study. Am. J. Public Health 113, 1201\u20131209 (2023).","journal-title":"Am. J. Public Health"},{"key":"67272_CR6","first-page":"e30","volume":"6","author":"BP Koen","year":"2020","unstructured":"Koen, B. P., COVID-19 Infection Survey Team et al. Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health 6, e30\u2013e38 (2020).","journal-title":"Lancet Public Health"},{"key":"67272_CR7","unstructured":"UK Health Security Agency. Winter Coronavirus (COVID-19) Infection Study: estimates of epidemiological characteristics, England and Scotland: 2023 to 2024. https:\/\/www.gov.uk\/government\/statistics\/winter-coronavirus-covid-19-infection-study-estimates-of-epidemiological-characteristics-england-and-scotland-2023-to-2024 (2023)."},{"key":"67272_CR8","doi-asserted-by":"crossref","unstructured":"Overton, C. E. et al. Epidemiological parameters of SARS-CoV-2 in the UK during the 2023\/2024 winter: a cohort study. J. Infect. 90, 106485 (2025).","DOI":"10.1016\/j.jinf.2025.106485"},{"key":"67272_CR9","unstructured":"Wolf, A., Hulmes, J. & Hopkins, S. Lateral flow device specificity in phase 4 (post-marketing) surveillance. https:\/\/www.gov.uk\/government\/publications\/lateral-flow-device-specificity-in-phase-4-post-marketing-surveillance (2021)."},{"key":"67272_CR10","doi-asserted-by":"crossref","unstructured":"Ward, T. et al. The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England. Nat. Commun. 15, 4633 (2024).","DOI":"10.1038\/s41467-024-47199-3"},{"key":"67272_CR11","doi-asserted-by":"crossref","unstructured":"Eyre, D. W. et al. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study. Lancet Infect. Dis. 23, 922\u2013932 (2023).","DOI":"10.1016\/S1473-3099(23)00129-9"},{"key":"67272_CR12","doi-asserted-by":"publisher","first-page":"eabh0635","DOI":"10.1126\/science.abh0635","volume":"373","author":"JA Hay","year":"2021","unstructured":"Hay, J. A. et al. Estimating epidemiologic dynamics from cross-sectional viral load distributions. Science 373, eabh0635 (2021).","journal-title":"Science"},{"key":"67272_CR13","unstructured":"UK Health Security Agency. SARS-CoV-2 genome sequence prevalence and growth rate update: 21 February 2024. https:\/\/www.gov.uk\/government\/publications\/sars-cov-2-genome-sequence-prevalence-and-growth-rate\/sars-cov-2-genome-sequence-prevalence-and-growth-rate-update-21-february-2024 (2024)."},{"key":"67272_CR14","doi-asserted-by":"crossref","unstructured":"Ward, T. et al. Bayesian spatial modelling of localised SARS-CoV-2 transmission through mobility networks across England. PLOS Comput. Biol. 19, e1011580 (2023).","DOI":"10.1371\/journal.pcbi.1011580"},{"key":"67272_CR15","doi-asserted-by":"crossref","unstructured":"Mossong, J. et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLOS Med. 5, e74 (2008).","DOI":"10.1371\/journal.pmed.0050074"},{"key":"67272_CR16","unstructured":"Singanayagam, A., ATACCC Study Investigators et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183\u2013195 (2022)."},{"key":"67272_CR17","doi-asserted-by":"crossref","unstructured":"Pellis, L., University of Manchester COVID-19 Modelling Group et al. Challenges in control of COVID-19: short doubling time and long delay to effect of interventions. Philos. Trans. R. Soc. B Biol. Sci. 376, 20200264 (2021).","DOI":"10.1098\/rstb.2020.0264"},{"key":"67272_CR18","unstructured":"UK Health Security Agency. The R value and growth rate. https:\/\/www.gov.uk\/guidance\/the-r-value-and-growth-rate (2022)."},{"key":"67272_CR19","doi-asserted-by":"crossref","unstructured":"Fyles, M. et al. Modelling multiplex testing for outbreak control. J. Infect. 89, 106303 (2024).","DOI":"10.1016\/j.jinf.2024.106303"},{"key":"67272_CR20","unstructured":"World Health Organisation. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic (2023)."},{"key":"67272_CR21","unstructured":"Office for National Statistics. Coronavirus (COVID-19) Infection Survey, UK: 24 March 2023. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/coronaviruscovid19infectionsurveypilot\/24march2023 (2023)."},{"key":"67272_CR22","unstructured":"Office for National Statistics. About the Winter Coronavirus (COVID-19) Infection Study. https:\/\/www.ons.gov.uk\/surveys\/informationforhouseholdsandindividuals\/householdandindividualsurveys\/wintercoronaviruscovid19infectionstudy\/aboutthewintercoronaviruscovid19infectionstudy (2025)."},{"key":"67272_CR23","doi-asserted-by":"crossref","unstructured":"Makhoul, M. et al. Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics. BMC Infect. Dis. 22, 458 (2022).","DOI":"10.1186\/s12879-022-07425-z"},{"key":"67272_CR24","doi-asserted-by":"crossref","unstructured":"Eales, O. & Riley, S. Differences between the true reproduction number and the apparent reproduction number of an epidemic time series. Epidemics 46, 100742 (2024).","DOI":"10.1016\/j.epidem.2024.100742"},{"key":"67272_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1467-9469.2008.00610.x","volume":"35","author":"F Lindgren","year":"2008","unstructured":"Lindgren, F. & Rue, H. On the second-order random walk model for irregular locations. Scand. J. Stat. 35, 691\u2013700 (2008).","journal-title":"Scand. J. Stat."},{"key":"67272_CR26","doi-asserted-by":"crossref","unstructured":"Rue, H. & Held, L. Gaussian Markov Random Fields (CRC Press, 2005).","DOI":"10.1201\/9780203492024"},{"key":"67272_CR27","doi-asserted-by":"crossref","unstructured":"Park, D. K., Gelman, A. & Bafumi, J. Bayesian multilevel estimation with poststratification: state-level estimates from national polls. Polit. Anal. 12, 375\u2013385 (2017).","DOI":"10.1093\/pan\/mph024"},{"key":"67272_CR28","doi-asserted-by":"crossref","unstructured":"Little, R. J. A. Post-stratification: a modeler\u2019s perspective. J. Am. Stat. Assoc. 88, 1001\u20131012 (1993).","DOI":"10.1080\/01621459.1993.10476368"},{"key":"67272_CR29","unstructured":"Office for National Statistics. Population projections. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationprojections (2024)."},{"key":"67272_CR30","unstructured":"Gabry, J., \u010ce\u0161novar, R., Johnson, A. & Bronder, S. cmdstanr: R Interface to \u2018CmdStan\u2019. R package version 0.9.0 https:\/\/mc-stan.org\/cmdstanr\/ (2025)."},{"key":"67272_CR31","unstructured":"Fyles, M. et al. The Winter Coronavirus (COVID-19) Infection Survey 2023-2024: estimating incidence and prevalence from lateral flow testing data, initial code release. https:\/\/zenodo.org\/records\/17209309."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67272-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:09:58Z","timestamp":1769213398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67272-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67272"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67272-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"834"}}